Literature DB >> 29666818

The role of positron emission tomography in the diagnosis, staging and response assessment of non-small cell lung cancer.

Sara Volpi1, Jason M Ali1, Angela Tasker2, Adam Peryt1, Giuseppe Aresu1, Aman S Coonar1.   

Abstract

Lung cancer is a common disease and the leading cause of cancer-related mortality, with non-small cell lung cancer (NSCLC) accounting for the majority of cases. Following diagnosis of lung cancer, accurate staging is essential to guide clinical management and inform prognosis. Positron emission tomography (PET) in conjunction with computed tomography (CT)-as PET-CT has developed as an important tool in the multi-disciplinary management of lung cancer. This article will review the current evidence for the role of 18F-fluorodeoxyglucose (FDG) PET-CT in NSCLC diagnosis, staging, response assessment and follow up.

Entities:  

Keywords:  Positron emission tomography (PET); diagnosis; follow up; non-small cell lung cancer (NSCLC); response assessment; staging

Year:  2018        PMID： 29666818      PMCID： PMC5890043          DOI： 10.21037/atm.2018.01.25

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


  67 in total

Review 1.  Systematic review of the cost-effectiveness of positron-emission tomography in staging of non--small-cell lung cancer and management of solitary pulmonary nodules.

Authors:  Jeffrey Q Cao; George B Rodrigues; Alexander V Louie; Gregory S Zaric
Journal:  Clin Lung Cancer       Date:  2011-12-01       Impact factor: 4.785

Review 2.  Non-small cell lung cancer.

Authors:  David S Ettinger; Wallace Akerley; Gerold Bepler; Matthew G Blum; Andrew Chang; Richard T Cheney; Lucian R Chirieac; Thomas A D'Amico; Todd L Demmy; Apar Kishor P Ganti; Ramaswamy Govindan; Frederic W Grannis; Thierry Jahan; Mohammad Jahanzeb; David H Johnson; Anne Kessinger; Ritsuko Komaki; Feng-Ming Kong; Mark G Kris; Lee M Krug; Quynh-Thu Le; Inga T Lennes; Renato Martins; Janis O'Malley; Raymond U Osarogiagbon; Gregory A Otterson; Jyoti D Patel; Katherine M Pisters; Karen Reckamp; Gregory J Riely; Eric Rohren; George R Simon; Scott J Swanson; Douglas E Wood; Stephen C Yang
Journal:  J Natl Compr Canc Netw       Date:  2010-07       Impact factor: 11.908

3.  Prognostic value of thoracic FDG PET imaging after treatment for non-small cell lung cancer.

Authors:  E F Patz; J Connolly; J Herndon
Journal:  AJR Am J Roentgenol       Date:  2000-03       Impact factor: 3.959

Review 4.  Meta-analysis of positron emission tomographic and computed tomographic imaging in detecting mediastinal lymph node metastases in nonsmall cell lung cancer.

Authors:  Ozcan Birim; A Pieter Kappetein; Theo Stijnen; Ad J J C Bogers
Journal:  Ann Thorac Surg       Date:  2005-01       Impact factor: 4.330

Review 5.  Adjuvant chemotherapy in completely resected non-small-cell lung cancer.

Authors:  Katherine M W Pisters; Thierry Le Chevalier
Journal:  J Clin Oncol       Date:  2005-05-10       Impact factor: 44.544

Review 6.  Staging of non-small cell lung cancer (NSCLC): a review.

Authors:  S Tsim; C A O'Dowd; R Milroy; S Davidson
Journal:  Respir Med       Date:  2010-09-15       Impact factor: 3.415

Review 7.  Lung cancer in Europe in 2000: epidemiology, prevention, and early detection.

Authors:  Jerzy E Tyczynski; Freddie Bray; D Maxwell Parkin
Journal:  Lancet Oncol       Date:  2003-01       Impact factor: 41.316

8.  Issues in quantification of registered respiratory gated PET/CT in the lung.

Authors:  Vesna Cuplov; Beverley F Holman; Jamie McClelland; Marc Modat; Brian F Hutton; Kris Thielemans
Journal:  Phys Med Biol       Date:  2017-12-14       Impact factor: 3.609

Review 9.  Noninvasive staging of non-small cell lung cancer: a review of the current evidence.

Authors:  Eric M Toloza; Linda Harpole; Douglas C McCrory
Journal:  Chest       Date:  2003-01       Impact factor: 9.410

Review 10.  PET/CT imaging in lung cancer: indications and findings.

Authors:  Bruno Hochhegger; Giordano Rafael Tronco Alves; Klaus Loureiro Irion; Carlos Cezar Fritscher; Leandro Genehr Fritscher; Natália Henz Concatto; Edson Marchiori
Journal:  J Bras Pneumol       Date:  2015 May-Jun       Impact factor: 2.624
View more
  19 in total

1.  Effect of blood glucose level on standardized uptake value (SUV) in 18F- FDG PET-scan: a systematic review and meta-analysis of 20,807 individual SUV measurements.

Authors:  Mahsa Eskian; Abass Alavi; MirHojjat Khorasanizadeh; Benjamin L Viglianti; Hans Jacobsson; Tara D Barwick; Alipasha Meysamie; Sun K Yi; Shingo Iwano; Bohdan Bybel; Federico Caobelli; Filippo Lococo; Joaquim Gea; Antonio Sancho-Muñoz; Jukka Schildt; Ebru Tatcı; Constantin Lapa; Georgia Keramida; Michael Peters; Raef R Boktor; Joemon John; Alexander G Pitman; Tomasz Mazurek; Nima Rezaei
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-10-22       Impact factor: 9.236

Review 2.  Radiation-Induced Lung Injury: Assessment and Management.

Authors:  Alexander N Hanania; Walker Mainwaring; Yohannes T Ghebre; Nicola A Hanania; Michelle Ludwig
Journal:  Chest       Date:  2019-04-15       Impact factor: 9.410

3.  Total-body PET/CT using half-dose FDG and compared with conventional PET/CT using full-dose FDG in lung cancer.

Authors:  Hui Tan; Xiuli Sui; Hongyan Yin; Haojun Yu; Yusen Gu; Shuguang Chen; Pengcheng Hu; Wujian Mao; Hongcheng Shi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-11-27       Impact factor: 9.236

4.  Thoracic surgery for lung cancer: current practice and future directions.

Authors:  Aman Coonar; Giuseppe Aresu; Adam Peryt; Jason Ali
Journal:  J R Soc Med       Date:  2019-01-30       Impact factor: 5.344

5.  PET Use in Cancer Diagnosis, Treatment, and Prognosis.

Authors:  Naresh Damuka; Meghana Dodda; Kiran Kumar Solingapuram Sai
Journal:  Methods Mol Biol       Date:  2022

6.  A comparative analysis: international variation in PET-CT service provision in oncology-an International Cancer Benchmarking Partnership study.

Authors:  Charlotte Lynch; Irene Reguilon; Deanna L Langer; Damon Lane; Prithwish De; Wai-Lup Wong; Fergus Mckiddie; Andrew Ross; Lorraine Shack; Thida Win; Christopher Marshall; Mona-Eliszabeth Revheim; Bolette Danckert; John Butler; Sabina Dizdarevic; Cheryl Louzado; Canice Mcgivern; Anne Hazlett; Cindy Chew; Martin O'connell; Samantha Harrison
Journal:  Int J Qual Health Care       Date:  2021-02-20       Impact factor: 2.038

7.  Repeatability of two semi-automatic artificial intelligence approaches for tumor segmentation in PET.

Authors:  Elisabeth Pfaehler; Liesbet Mesotten; Gem Kramer; Michiel Thomeer; Karolien Vanhove; Johan de Jong; Peter Adriaensens; Otto S Hoekstra; Ronald Boellaard
Journal:  EJNMMI Res       Date:  2021-01-06       Impact factor: 3.138

8.  The optimal timing of FDG-PET/CT in non-small cell lung cancer diagnosis and staging in an Australian centre.

Authors:  Anne Johnson; Richard Norman; Francesco Piccolo; David Manners
Journal:  BMC Pulm Med       Date:  2021-07-01       Impact factor: 3.317

9.  TP53 Status, Patient Sex, and the Immune Response as Determinants of Lung Cancer Patient Survival.

Authors:  Donald Freudenstein; Cassandra Litchfield; Franco Caramia; Gavin Wright; Benjamin J Solomon; David Ball; Simon P Keam; Paul Neeson; Ygal Haupt; Sue Haupt
Journal:  Cancers (Basel)       Date:  2020-06-11       Impact factor: 6.639

10.  Detection of circulating genetically abnormal cells in peripheral blood for early diagnosis of non-small cell lung cancer.

Authors:  Wei-Ran Liu; Bin Zhang; Chen Chen; Yue Li; Xin Ye; Dong-Jiang Tang; Jun-Cheng Zhang; Jing Ma; Yan-Ling Zhou; Xian-Jun Fan; Dong-Sheng Yue; Chen-Guang Li; Hua Zhang; Yu-Chen Ma; Yan-Song Huo; Zhen-Fa Zhang; Shu-Yu He; Chang-Li Wang
Journal:  Thorac Cancer       Date:  2020-09-28       Impact factor: 3.500
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.